Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 045348/0580 | |
| Pages: | 9 |
| | Recorded: | 03/26/2018 | | |
| Attorney Dkt #: | 30100-103971PF |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/31/2019
|
Application #:
|
15762488
|
Filing Dt:
|
03/22/2018
|
|
Publication #:
|
|
Pub Dt:
|
09/13/2018
| | | | |
|
Title:
|
HIGHLY EFFICIENT NRF2 ACTIVATORS-CO-RELEASING MOLECULE HYBRIDS, THEIR USE IN THE TREATMENT OF INFLAMMATORY OR CARDIOVASCULAR DISEASES AND THEIR PROCESS OF PREPARATION
|
|
|
Assignees
|
|
|
|
|
| 3, RUE MICHEL-ANGE |
| PARIS CEDEX 16, FRANCE 75794 |
|
|
|
|
|
| 61 AVENUE DU GENERAL DE GAULLE |
| CRETEIL, FRANCE 94010 |
|
|
|
|
|
| 101 RUE DE TOLBAIC |
| PARIS CEDEX 13, FRANCE 75654 |
|
|
Correspondence name and address
|
| |
DENNEMEYER & ASSOCIATES, LLC
|
| |
2 NORTH RIVERSIDE PLAZA
|
| |
SUITE 1500
|
| |
CHICAGO, IL 60606
|
Search Results as of:
05/24/2024 03:09 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
